"type of cancer" trang 2 - tải miễn phí từ tailieunhanh
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
8    45    1
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
12    64    1
Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells

Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells
12    40    1
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
9    37    1
Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer

Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer
19    27    1
Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: A retrospective cohort analysis

Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: A retrospective cohort analysis
11    42    1
Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: A national population-based retrospective cohort study

Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: A national population-based retrospective cohort study
10    21    1
Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey

Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey
20    1    1
Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer

Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer
12    6    1
Impact of diabetes type II and chronic inflammation on pancreatic cancer

Impact of diabetes type II and chronic inflammation on pancreatic cancer
13    37    1
Cancer incidence in patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai

Cancer incidence in patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai
8    74    1
Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort

Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort
10    74    0
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
6    65    1
Refinement of response assessment in neuro-oncology (RANO) using nonenhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas

Refinement of response assessment in neuro-oncology (RANO) using nonenhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas
10    47    1
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study
8    44    1
Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop

Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop
11    33    1
Human papillomavirus type 16 E1 mutations associated with cervical cancer in a Han Chinese population

Human papillomavirus type 16 E1 mutations associated with cervical cancer in a Han Chinese population
8    64    0
Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: A case report

Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: A case report
10    54    1
Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death

Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death
15    24    1
Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma

Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma
10    54    1